Aurobindo Pharma Ltd.

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1986

Chairman: K Ragunathan

Managing Director: N Govindarajan

Group: Aurobindo

Listing: NSE: AUROPHARMA, BSE: 524804

Headquarters: Hyderabad, Telangana

Website: www.aurobindo.com

Market cap: R 54,861.43 Cr

Revenue (TTM): R 24,461.65 Cr

Earnings (TTM): R 3,193.11 Cr

Cash: R 2,842.17 Cr

Total Debt: R 5,561.97 Cr

Promoters' ownership: 52.01%

Liquidity: High

52 Week range: R 288.85 - 996.85

Face value: R1.00

Shares outstanding: 58,59,38,609

10 Years Aggregate:

• CFO: 15,504.43 Cr
• EBITDA: 26,293.18 Cr
• Net Profit: 15,415.22 Cr